Includes COMPASS® consultation report, clinical pathology evaluation, bone marrow morphology (up to 20 stains and/or IHC antibodies), flow cytometry (up to 40 antibodies), cytogenetics and/or fluorescent in situ hybridization (FISH) (up to 14 probes), and molecular tests as medically necessary.
The cobas 4800 BRAF V600 Mutation Test is a real-time PCR assay intended for the qualitative detection of the BRAF V600E mutation in DNA extracted from formalin fixed, paraffin-embedded human tumor tissue.
HER2 protein is detected by a primary monoclonal rabbit anti-human HER2 antibody (clone 4B5). HER2 expression level is determined by the staining pattern and percentage of invasive tumor cells, and is interpreted in accordance with CAP/ASCO Guidelines.
PR protein is detected by a primary monoclonal rabbit anti-human PR antibody (clone 1E2). PR status is determined determined by the intensity and percentage of appropriately stained tumor cells, and is interpreted in accordance with CAP/ASCO Guidelines.
ER protein is detected by a primary monoclonal rabbit anti-human ER antibody (clone SP1). ER status is determined determined by the intensity and percentage of appropriately stained tumor cells, and is interpreted in accordance with CAP/ASCO Guidelines.
Genoptix offers a comprehensive catalog of over 200 high-quality IHC antibodies and stains including stains for leukemia, lymphoma, breast cancer, prostate cancer, and more. You can easily pick and choose from our full menu–available in both global (with interpretation) or tech-only (no interpretation) options. When you order as tech-only, you’ll receive your digital slide images within one business day. Then, simply analyze and interpret the results. With the Genoptix Report Builder tool, you can easily review digital slide images and build a customized professional report. Don’t have time? Convert your case to global, and one of our expert pathologists will perform the interpretation for you.
Genoptix offers pathologists an advanced tool to assess breast cancer biomarker status of Estrogen Receptor (ER), Progesterone Receptor (PR), HER2, and Ki-67. This imaging-based platform enables you to assess digital whole slide images, perform algorithmic calculations, and determine biomarker status via our easy-to-use, yet secure Report Builder™ website. By collaborating with Genoptix, you can work with a premier provider of Image Analysis by immunohistochemistry (IHC) technology using high quality standards and processes. The Genoptix Report Builder enables you to easily review digital slide images, score regions of interest, and build a customized professional report.
Includes COMPASS® consultation report, clinical pathology evaluation, blood morphology (up to 10 cytochemical stains), flow cytometry (up to 40 antibodies), cytogenetics and/or fluorescent in situ hybridization (FISH) (up to 14 probes), and molecular tests as medically necessary.
CONTACT US
Genoptix, a NeoGenomics Company
2131 Faraday Ave
Carlsbad, CA 92008
Phone: +1.760.268.6200
Fax: +1.760.268.6201
Client Services
Phone: +1.800.755.1605
Fax: +1.888.755.1604
Email: clientservices@genoptix.com
Medical Director: Derek Lyle, MD
Recent News
NeoGenomics Completes Acquisition of Genoptix, Inc.December 10, 2018 - 9:00 am- NeoGenomics Signs Definitive Agreement to Acquire GenoptixOctober 23, 2018 - 9:00 am
- Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib)September 4, 2018 - 8:30 am
HOURS OF OPERATION
Our lab is open six days a week:
5:00am to 6:00pm PT Mon-Fri
7:00am to 3:30pm PT Saturday
For after-hours assistance, your call
will be connected with an on-duty
Client Services Representative.
